Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 13427

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

1,929 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 8) (Last 30 Days: 37) (Since Published: 1929) 

Company Data

More News Results

  • 2025/08/26: Notification of cessation of securities - ACW*
  • 2025/08/26: ACW pharmacokinetics trial success*
  • 2025/08/25: Appendix 4G*
  • 2025/08/25: Corporate Governance Statement*
  • 2025/08/25: ACW FY2025 results - accelerating Alzheimers pivotal trial*
  • 2025/08/25: ACW Appendix 4E and 2025 annual report*
  • 2025/08/07: ACW CEO Q&A at Bioshares 2025*
  • 2025/07/30: Actinogen June 2025 quarterly activity report & Appendix 4C*
  • 2025/07/30: Notification of buy-back - ACW*
  • 2025/07/28: ACW presents key clinical data at AAIC dementia meeting*
*refer to company website